THDB(SH:600867)2022-04-28 16:00Financial Performance - The company's operating revenue for Q1 2022 was ¥887,477,252.42, representing a year-on-year increase of 7.85%[4] - The net profit attributable to shareholders was ¥831,206,165.81, showing a significant increase of 146.90% compared to the same period last year[4] - The basic earnings per share for the period was ¥0.41, reflecting a growth of 141.18% year-on-year[4] - Total operating revenue for Q1 2022 was ¥887,477,252.42, an increase of 7.97% compared to ¥822,877,442.06 in Q1 2021[19] - Net profit for Q1 2022 reached ¥831,177,167.14, a significant increase of 147.00% compared to ¥336,685,623.32 in Q1 2021[20] - Earnings per share for Q1 2022 was ¥0.41, compared to ¥0.17 in Q1 2021, marking a growth of 141.18%[21] - The total comprehensive income attributable to shareholders of the parent company for Q1 2022 was ¥831,206,165.81, compared to ¥336,658,081.42 in Q1 2021[21] Assets and Liabilities - Total assets reached ¥7,303,544,733.34, marking a 12.02% increase from the previous year[5] - The total assets as of Q1 2022 amounted to ¥7,303,544,733.34, an increase from ¥6,520,101,831.69 in the previous year[19] - The total liabilities as of Q1 2022 were ¥301,997,696.34, slightly up from ¥299,874,064.97 in the previous year[19] - Total current liabilities were reported at RMB 271,011,360.23, compared to RMB 268,552,310.27 in the previous year, showing a slight increase[16] - Non-current assets totaled RMB 4,397,685,201.79, a marginal increase from RMB 4,357,640,813.80 year-over-year[16] Cash Flow - The net cash flow from operating activities was ¥353,628,438.63, which decreased by 4.76% compared to the same period last year[4] - Cash inflow from operating activities for Q1 2022 was CNY 889,818,138.33, an increase from CNY 822,296,308.62 in Q1 2021, representing a growth of approximately 8.2%[22] - Total cash inflow from operating activities was CNY 353,628,438.63, down from CNY 371,302,361.29 in the same period last year, showing a decrease of about 4.9%[22] - The net increase in cash and cash equivalents for Q1 2022 was CNY 174,673,588.90, down from CNY 202,911,569.62 in Q1 2021, reflecting a decrease of about 13.9%[23] - The company reported a net cash outflow from financing activities of CNY -41,346,559.10 in Q1 2022, slightly improved from CNY -44,565,001.00 in Q1 2021[23] Investments - Investment income surged by 4240.60%, primarily due to the transfer of shares in a subsidiary[8] - The company reported an investment income of ¥530,762,988.19 in Q1 2022, a substantial increase from ¥12,227,878.38 in Q1 2021[19] - The company completed the transfer of 20,350,000 shares of Xiamen Te Bao Biological Engineering Co., Ltd. at a price of RMB 22.608 per share, totaling RMB 460,072,800[13] - A second transfer of 20,500,000 shares of Te Bao Biological was executed at RMB 20.16 per share, amounting to RMB 413,280,000, with the transfer still in process as of the report date[13] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 114,221, with the largest shareholder holding 29.44% of the shares[9] - The total equity attributable to shareholders of the parent company increased to ¥6,996,226,972.18 from ¥6,214,878,703.23, representing a growth of 12.55%[19] Research and Development - Research and development expenses for Q1 2022 were ¥29,327,431.35, down from ¥37,980,616.37 in Q1 2021, indicating a decrease of 22.83%[19] Inventory and Receivables - The company reported inventory of RMB 521,039,722.68, down from RMB 537,917,743.37, indicating a decrease of approximately 3.15%[15] - Accounts receivable increased to RMB 599,172,165.02 from RMB 559,472,847.32, reflecting a growth of approximately 7.07%[15] Cash and Cash Equivalents - The company's cash and cash equivalents amounted to RMB 1,039,713,134.29, up from RMB 865,039,545.39 in the previous year, indicating a year-over-year increase of about 20.19%[15] - Cash and cash equivalents at the end of Q1 2022 totaled CNY 1,039,713,134.29, up from CNY 594,943,313.72 at the end of Q1 2021, reflecting an increase of approximately 74.7%[23]